Furthermore, by targeting SNCA 5′-UTR, paroxetine demonstrated in vivo anti-amyloid efficacy in APP transgenic mice, with prolonged treatment against PD to inhibit synuclein translation of SNCA mRNA [77]. The gene discussed is APP; the disease is Parkinson disease.